{
  "ticker": "EMD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02970531",
  "id": "02970531",
  "pages": 29,
  "price_sensitive": false,
  "date": "20250718",
  "time": "1042",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250718/pdf/06lxkm7fj1p95c.pdf",
  "summary": "### **Material Information Summary (Emyria Limited \u2013 General Meeting Notice)**  \n\n#### **Key Resolutions for Shareholder Approval:**  \n1. **Ratification of Past Issuances:**  \n   - **UWA Shares:** 2,083,333 shares issued at $0.03/share (total ~$62,500) under Listing Rule 7.1 (Resolution 1).  \n   - **Tranche 1 Placement Shares:**  \n     - 71,290,790 shares under Listing Rule 7.1 (Resolution 2a).  \n     - 48,916,082 shares under Listing Rule 7.1A (Resolution 2b).  \n     - Total raised: **$4M (AUD)** at **$0.024/share**.  \n\n2. **Approval for New Issuances:**  \n   - **Tranche 2 Placement Shares:** 34,501,462 shares at $0.024/share (to raise ~$828K) (Resolution 3).  \n   - **Placement Options:** 51,569,445 free-attaching options (1:3 ratio) at $0.05 exercise price, 18-month expiry (Resolution 4).  \n   - **Director Participation:**  \n     - 11,958,333 shares + 3,986,111 options for Directors Winlo ($5K) and Hutchinson ($282K) (Resolutions 5a/b).  \n   - **Lead Manager Options:** 2,500,000 options to GBA Capital (Resolution 6).  \n   - **S3 Consortium Issuance:**  \n     - 6,250,000 shares + 2,083,333 options for investor relations services (Resolutions 7/8).  \n\n#### **Key Dates:**  \n- **Meeting Date:** 19 August 2025 (record date: 17 August 2025).  \n- **Tranche 2/Options Issuance Deadline:** Within 3 months post-meeting.  \n\n#### **Use of Funds (Placement):**  \n- Expand treatment programs (Medibank agreement).  \n- Placement costs and working capital.  \n\n#### **Voting Exclusions:**  \n- Votes from related parties/associates excluded for each resolution (e.g., UWA, participants in placements).  \n\n**Note:** No trading halt or capital raising timetable (already completed/firm commitments).  \n**Non-material:** Operational details, definitions, proxy instructions.  \n\n---  \n**Format:** Strictly factual, excluding boilerplate and legal disclaimers. Focused on implications for capital structure, dilution, and liquidity.",
  "usage": {
    "prompt_tokens": 16002,
    "completion_tokens": 543,
    "total_tokens": 16545,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-18T01:05:12.207866"
}